BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mönig S, van Hootegem S, Chevallay M, Wijnhoven BPL. The role of surgery in advanced disease for esophageal and junctional cancer. Best Pract Res Clin Gastroenterol 2018;36-37:91-6. [PMID: 30551863 DOI: 10.1016/j.bpg.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Aboul-Enein MS, Knight W, Wulaningsih W, Foley DM, Dellaportas D, Zylstra J, Baker CR, Kelly M, Smyth E, Lagergren J, Maisey N, Allum WH, Gossage JA, Cunningham D, Davies AR; Guy's and St Thomas' Oesophago-gastric Research Group. The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma. J Surg Oncol 2021. [PMID: 34403501 DOI: 10.1002/jso.26648] [Reference Citation Analysis]
2 Kassar S, Samaha R, Aoun R, Khoury M, Kattan J. The concept of oligometastatic disease in gastric cancer: reality or fiction? Future Oncol 2022;18:135-8. [PMID: 34889659 DOI: 10.2217/fon-2021-1315] [Reference Citation Analysis]
3 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp (Engl Ed) 2021;99:490-9. [PMID: 34353590 DOI: 10.1016/j.cireng.2021.07.006] [Reference Citation Analysis]
4 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp 2021;99:490-9. [PMID: 33894971 DOI: 10.1016/j.ciresp.2021.03.003] [Reference Citation Analysis]
5 Jung JO, Nienhüser H, Schleussner N, Schmidt T. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. Int J Mol Sci 2020;21:E951. [PMID: 32023907 DOI: 10.3390/ijms21030951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]